||NeuroThera® Efficacy and Safety Trial-3
A double-blind, randomized, sham-controlled, parallel group. multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 hours of stroke onset.
Purpose of this study: To investigate the safety and efficacy of transcranial laser therapy using NeuroThera® Laser System (NTS) in treatment of ischemic strokes within 24 hours of onset. This laser light can go through the skull and reach the brain without the need for surgery, allowing the brain to recover from the stroke.
Principal investigator: Jack Cochran, MD
Contact: Harleen Bath, MS, 703-207-7540, email@example.com